Company page

Chimeric Therapeutics Limited

Chimeric Therapeutics Limited (Ticker: CHM) is a public company listed on the Australian market, with a market capitalization of approximately AUD 1.94 million. The company focuses on developing innovative therapies in the field of cell and gene therapy. Chimeric Therapeutics aims to address significant unmet medical needs through its advanced research and development initiatives.